Jobs / Germany / Abbott Laboratories
Head of Medical Affairs, DACH
Abbott Laboratories · 🌍 Germany -München
Sponsorship verdict
No sponsorship evidence yet
No government record and no wording either way. Not a refusal — ask the recruiter.
- No government sponsor record hereNo government sponsor record covers this employer in this country.
- The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
- Can’t check pay against the visa rulesNo salary stated. Germany EU Blue Card needs at least €50,700 a year (shortage-occupation / recent-graduate: €45,934). Source: https://www.make-it-in-germany.com/en/visa-residence/types/eu-blue-card, rules effective 2026-01-01.
- Confirmed live todayWhen a source last listed this job as open.
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Why not apply?
No register record and no sponsorship wording in the posting. Worth asking the employer before investing significant time.
SponsorApply flags time-wasters so your applications go where they can land. These come from the posting's own wording — read the original listing to confirm. See better-fit alternatives →
Sponsor Radar — Abbott Laboratories
No government sponsor record covers this employer in this country.
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Abbott Laboratories →
About the role
JOB DESCRIPTION: Position Overview Exact Sciences now Abbott is dedicated to delivering patient critical answers across the cancer journey from early detection to treatment decision making. With a strong focus on people and an empathetic spirit, which fuels the company’s culture, driving them to create and deliver solutions rooted in the needs of patients, providers, and families. From earlier cancer detection to treatment guidance and monitoring, Exact Sciences now Abbott are helping people get the answers they need to make more informed decisions across the cancer continuum. With a leading portfolio of products for earlier detection and treatment guidance, they help people face the most challenging decisions with confidence with a dedication to continuously innovate, combining scientific rigor with an open-minded approach to deliver the next big thing. Exact Sciences is continuously expanding the pipeline with the aim of tackling a wider array of cancer tests through the following measures: • Expanding the Oncotype IQ platform to include liquid and tissue-based tests, all with the goal of making cancer care smarter. • Adapting biomarker-based technologies create a liquid biopsy capable of detecting cancers and precancers from a blood sample. • Using their proven multi-marker approach to achieve analytical sensitivity needed to discriminate between normal and cancerous samples. • Collaborating with world-class clinicians and scientists at Mayo Clinic to identify biomarkers associated with the 15 deadliest cancers. • Building a cancer detection platform upon learnings from the development of Cologuard® (commercially available in the US only). By 2020, Oncotype DX will have been used to guide treatment decisions for more than 1 million cancer patients worldwide in breast, prostate and colon cancer. The company’s global headquarters are in the United States and its International headquarters are in Zug, Switzerland. The International region includes Europe, Canada, Africa, Asia Pacific, Latin America. The Principal Medical Affairs, Germany is responsible for medical affairs activities in selected key markets across International. These markets will include Austria, Switzerland, Netherlands, Poland, Israel and the Middle East Africa region. The number of markets may increase in line with Exact Sciences continuing expansion in the international region. Representing the medical function, this individual manages research and educational medical objectives, while supporting commercial business and reimbursement objectives for the Oncotype DX portfolio of products, most notably, the Oncotype DX Breast Cancer Assay. Near term business objectives include supporting growth of the breast assay by partnering with local third-party organizations or providing direct support to the market. The Principal Medical Affairs, Germany plays a key role in providing medical information and education through scientific exchange in a fair-balanced manner to Medical Oncology, Surgeons, and Pathology Key Opinion Leaders as well as other healthcare professionals in breast cancer. In time, they may support other new product introductions in oncology. In addition, the role supports the company’s R&D and investigator-initiated studies in the development and commercialization of genomic assays that lead to improved treatment decisions for oncology patients. This position requires professionals with established personal and scientific creditability to interact with thought leaders, government health authorities, and medical centers of excellence. Essential Duties Include, but are not limited to, the following: • Develop a Medical Affairs Strategic Plan for the region, which include plans for Key Opinion Leader engagement, educational and